Anna Bustin, PharmD, BCPPS

female silhouette icon
Anna Bustin, PharmD, BCPPS, is a residency preceptor with the Pharmacy Residency Program and a clinical pharmacy specialist in Neonatal / Infant Intensive Care at Children's Hospital of Philadelphia.

Areas of Expertise: Neonatology, Parenteral nutrition, Pulmonary hypertension, Critical Care, Bronchopulmonary dysplasia, Chronic lung disease
Locations: Main Hospital
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training

Residency

Pharmacy Practice (PGY 1) - Children’s Hospital of Philadelphia, Philadelphia, PA

Pediatric Specialty (PGY 2) - Children’s Hospital of Philadelphia, Philadelphia, PA

Board Certification

Basic Life Support (BLS)
Board Certified Pediatric Pharmacy Specialist (BCPPS)
Pediatric Advanced Life Support (PALS)
Pharmacy-Based Immunization Certification

Undergraduate Degree

BS in Nutrition, University of Tennessee, Knoxville, TN

Graduate Degree

PharmD - Lipscomb University College of Pharmacy, Nashville, TN

Titles and Academic Titles

Clinical Pharmacy Specialist, Neonatal / Infant Intensive Care

Residency Preceptor, Pharmacy Residency Program

Departments and Services

Research Interests

Diazoxide induced pulmonary hypertension
IV compatibility
Neonatal status epilepticus
Hypoxic ischemic encephalopathy
Parenteral nutrition

Publications

Papers

2021

Serio J, Gattoline S, Collier H, Bustin A. Evaluation of sirolimus dosing in neonates and infants with lymphatic disorders.  J Pediatr Pharmacol Ther. J Pediatr Pharmacol Ther. 2022;27(5):447-458.



McElroy NA, Bustin A, Gattoline S.  Evaluation of the Safety of Ketorolac in Postsurgical Infants Less than Six Months of Age.  J Pediatr Pharmacol Ther. J Pediatr Pharmacol Ther. 2022;27(4):347–351

Sanseau E, et al.  Pediatric Emergency Medicine Simulation Curriculum: Vitamin K Deficiency in the Newborn. MedEdPORTAL. 2021;17:11078

2020

Bustin A, Ramsey EZ, Hanna BD, Kaushal G. Compatibility of treprostinil sodium and dopamine hydrochloride during Y-site administration. Am J Health-Syst Pharm. 2020;77:649-657

 

Posters and Presentations

2022

Napolitano N and Bustin A.  Utilization of Aerosolized Medications in sBPD: Evidence vs. Eminence-Based Medicine.  Eighth Annual Children’s Hospital of Philadelphia Chronic Lung Disease Conference.  Philadelphia, Pennsylvania.  June 2022.

Nelin TD.; Jensen EA.; Lorch S; Gibbs K; Alexiou S; Napolitano N; Bustin A; Huber M; Bamat NA.  Impact of novel loop and thiazide diuretic exposures on serum sodium, potassium, and chloride in infants with severe bronchopulmonary dysplasia.  Pediatric Academic Societies 2022 Conference.  Denver, Colorado.  April 2022.

Napolitano N, Malick E, Bamat NA, Bustin A, Gibbs K, Jensen EA, Panitch H.  Formoterol use in Infants with Severe Bronchopulmonary Dysplasia: A case series.  Society of Critical Care Medicine 2022 Conference.  Virtual Platform.  February 2022.

2021

Salmon M, Abend NA, Bustin A, Fitzgerald MP, Flibotte J, Fung FW, Parikh D, Massey SL. Seizure Management in Neonatal Hypoxic Ischemic Encephalopathy.  Child Neurology Society 2021 Annual Meeting. Poster Presentation.  Boston, MA.  October 2021.

2018

Monk HM, Rosano JV, Bustin A.  Characterization of the use, safety, and efficacy of hydromorphone in the neonatal and infant population.  2018 ASHP Midyear Meeting Poster Presentation.  Anaheim, California.  December 2018.

Leadership and Memberships

Memberships in Professional Organizations

Pediatric Pharmacy Association (PPA)

American Society of Health-System Pharmacists (ASHP)